Compare DOYU & TRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DOYU | TRX |
|---|---|---|
| Founded | 2014 | 1990 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.6M | 228.9M |
| IPO Year | 2019 | N/A |
| Metric | DOYU | TRX |
|---|---|---|
| Price | $7.06 | $0.89 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $7.00 | $1.25 |
| AVG Volume (30 Days) | 33.7K | ★ 1.4M |
| Earning Date | 11-20-2025 | 01-13-2026 |
| Dividend Yield | ★ 141.29% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | ★ $566,928,371.00 | $57,613,000.00 |
| Revenue This Year | N/A | $28.16 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $363.98 |
| Revenue Growth | N/A | ★ 39.98 |
| 52 Week Low | $5.68 | $0.27 |
| 52 Week High | $16.99 | $0.89 |
| Indicator | DOYU | TRX |
|---|---|---|
| Relative Strength Index (RSI) | 52.03 | 71.55 |
| Support Level | $6.58 | $0.82 |
| Resistance Level | $7.10 | $0.89 |
| Average True Range (ATR) | 0.22 | 0.05 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 70.77 | 94.94 |
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.
TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. It is focused on the Buckreef Gold Project which comprises five prospects, namely Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba.